Abstract 2050: Polyploid tumor cells: a chemoresistant cell type in triple-negative breast cancer
Authors: Gyanchandani Rekha , Lee Adrian 
Published: July 2017

Abstract
Background: Triple-negative breast cancers (TNBC) are associated with an extremely poor prognosis due to their aggressive behavior and rapid resistance to chemotherapy. Chemotherapy may select for resistant subclones and lead to tumor recurrence. Although, DNA aneuploidy has been a long known prognostic biomarker in breast cancer, the biological role of aneuploid or polyploid cancer cells in tumorigenesis and chemoresistance is largely undefined. Polyploid cells arise due to repeated rounds of DNA duplication in the absence of mitosis. Chemotherapeutic DNA-damaging agents or mitotic inhibitors can also induce formation of polyploid cells and subsequent senescence. However, recent reports indicate that polyploid cells represent a viable and proliferating subpopulation within a tumor that may escape chemotherapy and contribute to tumor recurrence.
Methods: In this study, we examined the prevalence and functional significance of polyploidy occurring de novo or induced by chemotherapy in TNBC cell lines. DNA ploidy was analyzed in Hoechst 33342 stained cells using FACS. Cells with greater than 4N DNA content were defined as polyploid. Live-cell imaging was done to observe cell division patters in polyploid cells using IncuCyte Zoom. Cell proliferation was assessed in the absence and presence of chemotherapy drugs with distinct modes of action (docetaxel and paclitaxel: mitotic inhibitors, cisplatin: DNA cross-linking agent, and etoposide or VP16: topoisomerase inhibitor). RNAseq was performed to compare gene expression profiles between treatment-naive diploid and polyploid cells.
Results: Hoechst 33342 staining determined the prevalence of polyploid cells in HCC1395(6.7%) and HCC1937 (5.8%) cells lines. Live-cell imaging in polyploid cells showed formation of mitotic structures suggesting multi-polar cell division. Cell proliferation assay revealed that polyploid cells grow slower than diploid cells and show reduced sensitivity to all four chemotherapy drugs. Docetaxel treatment resulted in induction of polyploidy and drug-induced senescence in parental TNBC cells. Drug-induced polyploid cells were resistant to subsequent docetaxel treatment. Time-lapse imaging showed budding of small daughter cells from polyploid senescent cells. Majority of senescent cells died, some cells survived and regenerated the diploid and polyploid subpopulations similar to those present in parental cells. RNAseq identified differentially expressed genes involved in G1-S and G2-M checkpoint pathways (BRCA1/2, RAD51), cell proliferation (Aurora kinase A/B) and apoptosis (BIM, BIRC3).
Conclusions: Above findings indicate that there are molecular and functional differences between diploid and polyploid cells that are both naturally occurring or induced by chemotherapy. In our future studies, we will examine combinatorial approaches to overcome polyploidy-associated chemoresistance.
Citation Format: Rekha Gyanchandani, Adrian Lee. Polyploid tumor cells: a chemoresistant cell type in triple-negative breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2050. doi:10.1158/1538-7445.AM2017-2050